April 24-26 – Chicago, IL
Philips at Heart Rhythm 2026
Empower your cardiac service line and help provide better care for more people
From specialized diagnostic and treatment solutions, to data management and monitoring, our cardiac ecosystem is designed to keep you at the forefront of technology with solutions spanning across home and hospital. Make confident clinical decisions, streamline your cardiac service line and navigate the most challenging cases with clarity through powerful data, clear visualization and effective tools, all from one trusted partner.
Heart Rhythm Theater at HRS 2026
Beyond the Lead: Hot Topics and Contemporary Trends in Lead Management
Join the interactive discussion around the latest considerations, growing indications, and data-driven insights in a case-based approach to managing CIED patients with actionable applications to elevate lead management at your institution.
April 24, 2026
10:30 – 11:30 am CST
Rhythm Theater #1
Speakers
- Dr. Rohit MehtaCardiac Electrophysiology, Global Cardiac EP, Charlotte, NC, USA
- Dr. Emily ZeitlerCardiologist, Dartmouth Health, Lebanon, NH, USA
- Dr. Rob LewisAssistant Professor of Medicine, Duke University Hospital , Raleigh, NC, USA
- Dr. Graham PeighAssistant Professor Cardiology, Medicine Northwestern Medical Group , Chicago, IL, USA
Heart Rhythm Theater at HRS 2026
One Platform. Multiple Possibilities. The Future of ICE in EP.
Join the engaging discussion on the evolving role of advanced ICE imaging in electrophysiology. Discover the impact of ICE on workflows and patient care, including concomitant LAAO and ablation procedures, and go beyond conventional 2D ICE with new solutions, all on one platform.
April 24, 2026
12:00 – 1:00 pm CST
Rhythm Theater #1
Speakers
- Dr. Shephal DoshiChair in Cardiac Electrophysiology, Pacific Heart Institute, Santa Monica, CA, USA
- Dr. Anish AminChair in Heart Health & Cardiac Arrhythmias, OhioHealth Riverside, Columbus, OH, USA
- Dr. Suneet MittalDirector of Electrophysiology, Valley Hospital, Ridgewood, NJ, USA
Heart Rhythm Theater at HRS 2026
AF Detection Is No Longer the Bottleneck—Our Thinking Is
Join an essential discussion around the risks and burdens of delayed AF diagnosis and a fragmented care pathway. As AI-enabled technologies and ambulatory monitoring expands, system-wide integration and clinical capacity are the true constraints. If we started over today, would we diagnose and manage AF the same way?
April 24, 2026
1:30 – 2:30 pm CST
Rhythm Theater #1
Speakers
- Dr. Mohammad-Ali JazayeriCardiac Electrophysiology, Michigan Heart (IHA/Trinity Health), Ypsilanti, MI, USA
- Dr. Harish ManyamChief of Cardiology, Erlanger Health System, Chattanooga, TN, USA
- Dr. Matthew R. ReynoldsCardiac Electrophysiology, Lahey Health, Burlington, MA, USA
- Dr. Samuel F. Sears, JrCardiac Psychology, East Carolina University, Greenville, NC, USA
Maintain control, transition to surgery, save lives
In the rare event of an SVC tear [1], deploy the new Bridge Plus Occlusion Balloon in under two minutes.[2] Stop up to 90% of blood loss and provide acceptable hemostasis for at least 30 minutes. [3,4]
Sessions, workshops and demos
Booth presentation
Where Clinical Excellence Meets Efficiency: A Philips EP Experience with Dr. Jason Chinitz at South Shore University Hospital
April 25, 2026
10:00 – 10:30 am CST
Philips Booth #704
Booth presentation
AI for EPs Today and in the Future: Early Detection of Arrhythmia
April 25, 2026
11:30 – 12:15 pm CST
Philips Booth #704
Booth presentation
Leveraging Technology for Patient Identification Strategies with Dr. Anne Kroman
April 25, 2026
2:45 – 3:15 pm CST
Philips Booth #704
New: Transform traditional 2D ICE with exceptional images and more control
Footnotes
- Roger G. Carrillo, MD; Darren C. Tsang, BS; Ryan Azarrafiy, BA; Thomas A. Boyle, BS. Multi-Year Evaluation of Compliant Endovascular Balloon in Treating Superior Vena Cava Tears During Transvenous Lead Extraction. EHRA late-breaking trial, March 19, 2018.
- Document on file, D026197 & animal study - NGX028-IS17 - All animals had biological metrics measured for up to 45 minutes during occlusion and 15 minutes post device deployment.
- Document on file D002023609_A_Bridge M&M Marketing Claims Test Report. Average timed deployment for commercial Bridge was 74.33 seconds and Bridge Plus was 58.33 seconds.
- Document on File, D027561 Marketing claims blood loss report for Bridge project 1338 - When deployed, the Bridge Occlusion Balloon reduces blood loss of an SVC tear by 89.7% (α=0.10), on average, in an animal model
Disclaimer
Results are specific to the institution where they were obtained and may not reflect the results achievable at other institutions. Results in other cases may vary.